HOME >> BIOLOGY >> NEWS
Virginia Tech researchers receive $450,000 award to model cell division

BLACKSBURG, Va., June 26, 2002 Cancer is a group of diseases involving misregulation of cell growth and division. The more we know about how cells grow and divide under normal circumstances, the better we will understand how things go awry in cancer cells.

For this reason, John Tyson, University Distinguished Professor of Biology at Virginia Tech, and Bela Novak, professor of biotechnology at the Budapest University of Technology and Economics, are developing mathematical models of the molecular mechanisms that control the way yeast cells grow and assume various shapes.

Their work is being supported by a $450,000 grant from the James S. McDonnell Foundation of St. Louis, Mo.

"Division and shape are important to yeasts because, by growing in specific directions, they are able to seek out viable environments and potential mates," Tyson said. "Understanding how yeast cells control these processes is important to us not only because of the cancer connection, but also because we are still very much in the dark about how genes regulate behavior in the broadest sense.

"While the genome project has provided a parts list of the cell, scientists need a schematic diagram of how all those parts hook together," Tyson said. "From the schematic diagram, we can write equations that govern the behavior of the control system, much like an electrical engineer can write equations for a circuit diagram. With these equations we can predict how a cell will behave under many different conditions."

Although a human cell is more evolved than a yeast cell, a human cell is made of the same sorts of parts that behave in the same way. It was found that "the molecular constituents of the cell cycle control system are functionally interchangeable between yeast and humans," Tyson said. "What we learn about cell division in yeast can be carried over to humans." From what they learn about the molecular mechanism of yeast cell growth and division, Tyson
'"/>

Contact: John Tyson
tyson@vt.edu
540-231-4662
Virginia Tech
26-Jun-2002


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
6. Virginia Center for Coal and Energy Research helps implement global climate change initiative
7. Cell cycle research earns biologist Virginias top scientist award
8. Virginia Tech-led group receives third five-year international biodiversity grant
9. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
10. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
11. Virginia Bioinformatics Institute central to Regional Center of Excellence

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Virginia Tech researchers receive award model cell division

(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
(Date:7/2/2015)... TN (PRWEB) , ... July 02, 2015 , ... ... the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition ... contract-manufacturing and the world's largest provider of surgical instruments to the Spine Industry. ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)... ... 2015 , ... The next-generation sequencing (NGS) clinical market is poised for huge ... industry. BCC Research reveals in its new report that the market drivers of this ... growing need for better diagnostics as part of a molecular diagnostics trend. , The ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
Cached News: